< Back to previous page
Researcher
Frederic Rousseau
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Switch Laboratory (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2012 → Today - SCHYMKOWITZ AND ROUSSEAU LAB (Research group)
Responsible
From1 Jan 2017 → Today - Switch Laboratory (VIB-KU Leuven) (Division)
Member
From1 Jan 2011 → Today - Department of Cellular and Molecular Medicine (Department)
Member
From15 Sep 2010 → 31 Dec 2010
Projects
1 - 10 of 62
See also Frederic Rousseau for projects of Flanders Institute for Biotechnology.
Here below the projects of KU Leuven.
- Switch-ALight on: Shedding light on the molecular mechanisms of AL amyloidosisFrom1 Nov 2025 → TodayFunding: FWO junior postdoctoral fellowship
- Assessing the interplay between ribosome pausing, co-translational folding, and proteostasis decline in ageingFrom1 Oct 2025 → TodayFunding: FWO junior postdoctoral fellowship
- Modeling Human Neuronal Vulnerability and Resilience in Alzheimer’s DiseaseFrom16 May 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Discovery and functional characterization of cyclic peptides in restoring alphab-crystallin pathogenic protein folding.From1 May 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The biomarker potential of extracellular vesicles and cryptic proteins in neurodegenerative disorders.From29 Apr 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Acquisition of a cryo-holder for an existing JEOL F200 electron microscope to enable structural biology applications in the context of human diseaseFrom1 Jan 2025 → TodayFunding: BOF - scientific equipment program
- Acquisition of a cryo-holder for an existing JEOL F200 electron microscope to enable structural biology applications in the context of human diseaseFrom1 Jan 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Heterotypic Protein Interactions in Neurodegenerative DiseasesFrom23 Sep 2024 → TodayFunding: FWO fellowships
- Synthetic antibodiesFrom26 Aug 2024 → TodayFunding: IOF - technology validation in lab
- The role of natural synonymous mutations in phenotypic diversityFrom12 Feb 2024 → TodayFunding: BOF - doctoral mandates
Publications
1 - 10 of 186
See also Frederic Rousseau for publications of Flanders Institute for Biotechnology.
Here below the publications of KU Leuven.
- From computational design to synthetic antibodies: a rational approach to antibody discovery(2025)
- A versatile platform for combinatorial antibody library cloning and NGS-based quality control with high accuracy(2025)Published in: Nucleic Acids ResearchISSN: 0305-1048Issue: 19Volume: 53
- Toward a thermodynamic taxonomy of amyloid fibrils(2025)Published in: StructureISSN: 0969-2126Issue: 10Volume: 33Pages: 1628 - 1630
- AXZ viewer: a web application to visualize unprocessed AFM-IR data(2025)Published in: BioinformaticsISSN: 1367-4803Issue: 10Volume: 41
- [11C]HSP990 PET as a translational tool to investigate the role of Hsp90 in tumours and support the development of Hsp90 therapeutics(2025)Published in: EJNMMI Radiopharmacy and ChemistryISSN: 2365-421XIssue: 1Volume: 10
- Untangling Alzheimer's Disease: From nanoscale spectroscopy to cellular vulnerability(2025)
- Chemical Synthesis of Medin via a Removable Aggregation-Suppressing Linker(2025)Published in: JOURNAL OF PEPTIDE SCIENCEISSN: 1075-2617Issue: 8Volume: 31
- EXPLORING HSP90 AS A TARGET FOR CANCER PET IMAGING(2025)
- Mimicking the structure and function of tau folds associated with disease(2025)Published in: Nature ChemistryISSN: 1755-4330Issue: 6Volume: 17Pages: 793 - 794
- TDP-43 seeding induces cytoplasmic aggregation heterogeneity and nuclear loss of function of TDP-43(2025)Published in: NeuronISSN: 0896-6273Issue: 10Volume: 113Pages: 1597 - 1613
Patents
1 - 10 of 10
- Means and methods for the treatment of pathological aggregation
- Means and methods for the prediction of amyloid core sequences
- Molecules targeting proteins
- Molecules targeting ras protein
- Molecules targeting mutant ras protein
- Carbon dioxide generation
- Beta-lactamase inhibitors
- Molecules targeting mutant ras protein
- Means and methods for the prediction of amyloid core sequences
- Means and methods for the treatment of pathological aggregation
Linked dataset
1 - 3 of 3
- Composition and liquid-to-solid maturation of protein aggregates contribute to bacterial dormancy development and recovery
- Composition and liquid-to-solid maturation of protein aggregates contribute to bacterial dormancy development and recovery
- Composition and liquid-to-solid maturation of protein aggregates contribute to bacterial dormancy development and recovery